News

Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at hscora@ouhsc.edu so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, September 10, 2018

NSF SEEKS HIGHER ED INPUT

The National Science Foundation (NSF) announces the launch of the NSF 2026 Idea Machine,

a prize competition to help set the U.S. agenda for fundamental research in science, technology,

engineering, and mathematics (STEM) and STEM education. Participants can earn cash prizes

and receive public recognition by suggesting the pressing research questions that need to be

answered in the coming decade, the next set of “Big Ideas” for future investment by NSF. It's an

opportunity for researchers, the public and other interested stakeholders to contribute to NSF's

mission to support basic research and enable new discoveries that drive the U.S. economy,

enhance national security and advance knowledge to sustain the country's global leadership in

science and engineering.

Entries will be accepted through October 26, 2018. For more information, including entry instructions,

eligibility, rules, and judging criteria, please visit the

https://www.nsf.gov/news/special_reports/nsf2026ideamachine/index.jsp

 

 

The Office of Technology Development will offer the Innovation to Impact Series Session 2

“Align Your Research With Industry.” You will explore: How to gather useful insights form the market,

Common customer discovery mistakes, and Funding to support market discovery.

This session will occur on September 26th  from Noon- 1:00 pm in Biomedical Research Center Building,  

Room 103. Lunch will be provided.

Please RSVP to rashaffer@ou.edu by September 20th. Space is limited to the first 15 attendees.

 

 

NIH UPDATE!! Effective immediately, Just-in-Time requests for information require

completion of a Foreign Involvement Section. 

This requires the PI to verify the following:

1.    collaborator’s name (IF NOT PROVIDED)

2.    name and address of the foreign site; (IF NOT PROVIDED IN SF424)

3.    estimated total costs of the foreign component/site (if/any) for each year;

4.    brief narrative that includes description of the work that will be performed at each foreign site.

5.    the involvement of human subjects or animals;

6.    extensive foreign travel by grantee project staff for the purpose of data collection, surveying,

                          sampling, and similar activities;

7.    any activity that may have an impact on U.S. foreign policy through involvement in the affairs of

                          environment of a foreign country;

8.    collaboration with investigators at foreign site anticipated to result in co-authorship

9.    use of facilities or instrumentation be used at foreign site;

           10.    receipt of financial support or resources from a foreign entity.

There are additional requirements for NIH-funded institutions regarding foreign influence and partners.  

We will provide more information as it becomes available.

 

 

Federal Websites that will satisfy the Revised Common Rule’s requirement to post clinical

trial consent forms (45 CFR 46.116(h)) - The U.S. Department of Health and Human Services (HHS) and

16 other federal departments and agencies are announcing where clinical trial consent forms can be posted,

as will be required by the revised Common Rule. No obligations to post such consent forms apply before

January 21, 2019. 
The revised Common Rule requires that for any clinical trial conducted or supported by a Common Rule

department or agency, one consent form be posted on a publicly available federal website within a specific

time frame.  The consent form must have been used in enrolling participants in order to satisfy this new

provision.  You can read more information about the revised Common Rule on the OHRP website

(https://www.hhs.gov/ohrp/education-and-outreach/revised-common-rule/index.html).
At this time, two publicly available federal websites that will satisfy the consent form posting requirement,

as required by the revised Common Rule, have been identified: ClinicalTrials.gov and a docket folder on

Regulations.gov (Docket ID: HHS-OPHS-2018-0021).  HHS and other Common Rule departments and

agencies are developing instructions and other materials providing more information to the regulated

community about this posting requirement. 
 

 

The National Science Foundation (NSF) is committed to ensuring a fair, competitive, and

transparent merit review process. The reviews submitted by external peer reviewers are an important

part of the decision-making process and a crucial source of feedback to Principal Investigators. NSF

has developed a short reviewer orientation video that provides helpful tips for writing high quality reviews.  

NSF encourages all reviewers to watch the orientation video, “The Art and Science of Reviewing Proposals,

”which can be accessed in FastLane through the Panelist Travel and Reimbursement page and the

Proposal Review, Ad Hoc Reviewers page. You can also view the video directly at 

https://tipsforreviewers.nsf.gov

There is a link at the end of the video to additional resources, a list of helpful hints, and a short

feedback survey. NSF values your feedback and will use the results of the survey improve future reviewer

orientation materials.

 

  

Harold Hamm Diabetes Center (HHDC) Research Symposium CALL FOR ABSTRACTS

The abstract submission deadline for the HHDC 2018 Research Symposium is Friday, October 5th

Abstracts must be received by 5 p.m. HHDC 2018 Research Symposium will be held on Friday,

November 16, 2018 at the Samis Education Center in Children’s Hospital in Oklahoma City. The

Symposium will consist of selected oral presentations, a poster session, and Symposia talks by Silvia

Corvera, MD, Professor, University of Massachusetts Medical School, Timothy McGraw PhD, Professor,

Cornell Weill College of Medicine and Morris White, PhD, Professor, Harvard University.  For abstract

submission guidelines and to RSVP for this free event, please go to: 

http://www.haroldhamm.org/Research/Symposium.aspx  Please contact Katie-Hoefling@ouhsc.edu 

with any questions for this event.

 

 

NOW ACCEPTING APPLICATIONS – Funding to complete the Master of Science degree

in Clinical and Translational Sciences

Now seeking applications for the NIMHD-funded research training and career development program. 

The goal of the program is to facilitate the education of participants from diverse backgrounds under-

represented in biomedical research to pursue clinical research or population health research on diseases

that disproportionately impact minority and rural populations in Oklahoma. 

The program provides two years of partial salary and research support to complete the Master of Science

degree in Clinical and Translational Sciences (MS in CTS) that is administered through the OUHSC

Graduate College.  To be eligible, applicants must hold a clinical doctoral degree or PhD, be from a group

underrepresented in biomedical research (racial and ethnic groups that have been shown by the National

Science Foundation to be underrepresented in biomedical research or individuals with disabilities), be within

seven years of their first faculty appointment, AND plan to pursue a research career focused on minority

health or health disparities research.  The 2-year program covers 50% protected time (salary+fringe), tuition

and fees for the MS in CTS degree program, travel to professional meetings, and modest research funds.

Applications are due 10/15/18. 

Program and eligibility information is attached.  Application materials can be found at: 

http://osctr.ouhsc.edu/clinical-research-education-and-career-development

For additional information, please contact Julie Stoner, PhD (julie-stoner@ouhsc.edu).

 

 

Prism Software Offered Through OUHSC Library - Graduate students and Post-docs have

been emailed information for access to a free license for Prism software.  Funding for these licenses

was provided by the Provost.  With this bulk purchase the Library is again offering Prism licenses to

other campus users at the greatly discounted cost of $45/license.

Licenses expire every year, information about the software, licensing and purchase can be found at 

http://library.ouhsc.edu/Prism.   If you have questions after reading the information on the web site,

please direct them to bhsladm@ouhsc.edu.

 

 

BIOMEDICAL WASTE DISPOSAL

The OUHSC contracted biomedical waste vendor (Stericycle) has expressed a concern regarding the

presence of liquid formalin or other preservatives being improperly disposed of in biomedical waste

containers: Please see attached document for additional information. 

https://research.ouhsc.edu/Portals/1329/Assets/Documents/Medical Waste Alert Notice.docx?ver=2018-08-27-073124-643

 

Diabetes Research: Pilot Project Funding Available – Mentoring Diabetes Research in Oklahoma

CoBRE – Proposal Deadline is September 14, 2018.  See attached document for additional information.

https://research.ouhsc.edu/Portals/1329/Assets/Documents/Pilot Projects in Diabetes COBRE flyer 2018.pdf?ver=2018-08-27-072837-087

 

END2CANCER: Emerging Nanotechnology and Drug Delivery Applications for Cancer Conference

Dates: December 6-7, 2018

Location: Samis Education Center

Registration and Call for Abstracts: http://end2cancer.com/

Summary: The END2CANCER conference will start the morning of December 6th, 2018 and conclude in

the afternoon of December 7th, 2018. The conference will bridge laboratory research conducted in the

areas of nanotechnology and drug delivery to clinical application for the detection, diagnosis, imaging and

treatment of cancer. The conference will host keynote, plenary and invited lectures by eminent scientists

who will discuss new and emerging concepts, technologies and challenges in translating nanomedicine

from bench-to-bedside.

Topics to be discussed in the planned thematic sessions include barriers in drug delivery, discovery and

applications, biological and non-biological systems as carriers and therapeutics, molecular imaging,

biomimetics, immune-oncology, toxicology and clinical trials.

The multi-disciplinary two-day conference will bring together physicians, basic scientists, engineers,

physicists, chemists, post-doctoral fellows, high-school and college students, patient advocates,

business professionals, educators and technology transfer specialists. Students and fellows will have an

opportunity to present their work as a poster presentation and compete for awards.

 

 

The Oklahoma Clinical and Translational Science Institute (OCTSI) and Oklahoma Shared Clinical and

Translational Resources (OSCTR) is soliciting applications for its Clinical and Translational Research

Pilot (CTRP) Grants Program. The purpose of the program is to provide funding for collaborative and/or

multi-disciplinary clinical and translational pilot projects between investigators of the OSCTR member institutions.

The program seeks to support proposals designed to generate preliminary data that will result in improved

health and/or healthcare for citizens of Oklahoma and other IDeA states and enhance the competitiveness

of the investigators for future extramural funding. The program also seeks to fund innovative concepts,

approaches, and methodologies that bring fresh new ideas to solving the health issues of those living in

Oklahoma and collaborating IDeA states. Projects that focus on the medically underserved and on health

concerns prevalent within Oklahoma and our OSCTR partners will be a priority. Only projects which meet

the NIH definition of clinical and/or translational research will be accepted. Proposals are due

September 21, 2018.  More information can be found at http://osctr.ouhsc.edu/pilots2018/

 

 

The Oklahoma Center for Respiratory and Infectious Diseases (OCRID) invites applications

for FY2019 Pilot Project Grants through the NIH CoBRE, with the Center for Veterinary Health Sciences

(CVHS), Oklahoma State University (OSU) and the participation of other OSU colleges, the University of

Oklahoma (OU) Health Science Center (HSC) and Norman, and the Oklahoma Medical Research Foundation

(OMRF).  Application Deadline is September 14, 2018.  See attached for more complete information.

https://research.ouhsc.edu/Portals/1329/Assets/Documents/COBRE-OCRID-2018-2019.pdf?ver=2018-08-27-072855-823

 

i2E Entrpreneurial Summit

This annual entrepreneurial event will give you tips, tricks and strategies for entrepreneurs.

Hear from local successful entrepreneurs as they share their personal stories on how they

got started, their successes and their failures. To be held Friday, September 28, 2018.

See attachment for additional information and registration.

https://research.ouhsc.edu/Portals/1329/Assets/Documents/i2e.pdf?ver=2018-08-27-072850-073

 

NIH NOTICES

 

NIH Request for Public Comment on the Draft Protocol Template for Behavioral and Social Sciences

Clinical Trials (NOT-OD-18-167)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-167.html

 

Notice of Increases to the Simplified Acquisition and Micro-purchase Thresholds by the Office of

Management and Budget (NOT-OD-18-219)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-219.html

 

Protecting Human Research Participants (PHRP) Online Tutorial No Longer Available as of September

26, 2018 (NOT-OD-18-221)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-221.html

 

Notice of Information: Re-instituting Payments for the NIA Aging Cell Repository/NIA Cell Bank

Collections (NOT-AG-18-026)
https://grants.nih.gov/grants/guide/notice-files/NOT-AG-18-026.html

 

Notice of Intent to Publish Funding Opportunity Announcements for the NIA Demography and Economics

of Aging Centers Program (NOT-AG-18-027)
https://grants.nih.gov/grants/guide/notice-files/NOT-AG-18-027.html

 

Correction to the Application Forms Package issued for RFA-AI-18-036 Leadership Group for a Clinical

Research Network on Antibacterial Resistance (UM1 Clinical Trial Required) (NOT-AI-18-056)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-18-056.html

 

Notice of Change to NIAMS Acceptance of Diversity and Re-Entry Supplement Applications

(NOT-AR-19-011)
https://grants.nih.gov/grants/guide/notice-files/NOT-AR-19-011.html

 

Notice of Updated Application Forms Package for Pre-Application: Research Innovation for Scientific

Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not Allowed) (NOT-AR-19-016)

https://grants.nih.gov/grants/guide/notice-files/NOT-AR-19-016.html

 

Notice of Updated Application Forms Package for Pre-Application: Research Innovation for Scientific

Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed) (NOT-AR-19-017)
https://grants.nih.gov/grants/guide/notice-files/NOT-AR-19-017.html

 

Notice of Availability of Administrative Supplements to NCCIH Grants to Address Opioid Use Disorder

and/or Pain (NOT-AT-18-013)
https://grants.nih.gov/grants/guide/notice-files/NOT-AT-18-013.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for Promoting Research on Music and

Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional) (NOT-AT-18-015)
https://grants.nih.gov/grants/guide/notice-files/NOT-AT-18-015.html

Notice of NCI Participation in RFA-ES-18-011, Human Health Exposure Analysis Resource: Targeted

Exposure Analysis Laboratories (U2C Clinical Trial Not Allowed) (NOT-CA-18-101)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-18-101.html

 

Notice of NCI Participation in RFA-ES-18-012, Human Health Exposure Analysis Resource: UnTargeted

Exposure Analysis Laboratories (U2C Clinical Trial Not Allowed) (NOT-CA-18-102)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-18-102.html

 

Notice of Change to Application Review Information in PAR-18-801 "Cancer Prevention, Diagnosis, and

Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional)" (NOT-CA-18-103)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-18-103.html

 

Notice of Change to Application Review Information in PAR-18-802, "Cancer Prevention, Diagnosis, and

Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional)" (NOT-CA-18-104)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-18-104.html

 

Notice of Change in Research Objectives for PAS-16-033, Stimulating Hematology Investigation:

New Endeavors (SHINE) (R01) (NOT-DK-18-020)
https://grants.nih.gov/grants/guide/notice-files/NOT-DK-18-020.html

 

Notice of Intent to Publish Funding Opportunity Announcements for the Collaborative Pediatric Critical

Care Research Network (CPCCRN) (R01 Clinical Trial Optional) (NOT-HD-18-013)
https://grants.nih.gov/grants/guide/notice-files/NOT-HD-18-013.html

 

Notice of Pre-Application Information Webinar and Frequently Asked Questions (FAQs) for NIH and USDA

Prospective Applicants to PAR-17-482 Comparative Genomics Research Program (R01-Clinical Trial Not

Allowed)" (NOT-HG-18-015)
https://grants.nih.gov/grants/guide/notice-files/NOT-HG-18-015.html

 

NHLBI Interest in Administrative Supplements to Enhance HIV-related Heart, Lung, Blood, and Sleep Research

(NOT-HL-18-648)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-648.html

 

NHLBI Announces Availability of Frequently Asked Questions (FAQs) for PAR-18-643 "NHLBI Clinical Ancillary

Studies (R01- Clinical Trial Optional)" (NOT-HL-18-649)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-649.html

 

Notice of Corrections to RFA-MD-18-011, "Limited Competition: RCMI Research Coordination Network

(RRCN) (U54 Clinical Trial Not Allowed)" (NOT-MD-18-013)
https://grants.nih.gov/grants/guide/notice-files/NOT-MD-18-013.html

 

Notice to Extend PAR-18-267 "Pilot Services Research Grants Not Involving Interventions

(R34 Clinical Trial Optional)" (NOT-MH-18-041)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-18-041.html

 

Notice of Extension of the Expiration Date for RFA-MH-18-702 "Early Stage Testing of Pharmacologic or

Device-based Interventions for the Treatment of Mental Disorders (R61/R33-Clinical Trial Required)"

(NOT-MH-18-043)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-18-043.html

 

Notice of Extension of the Expiration Date for RFA-MH-18-703 "Early Stage Testing of Pharmacologic or

Device-based Interventions for the Treatment of Mental Disorders (R33-Clinical Trial Required)"

(NOT-MH-18-044)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-18-044.html

 

Notice of Extension of the Expiration Date for RFA-MH-18-704 "Development of Psychosocial

Therapeutic and Preventive Interventions for Mental Disorders (R61/R33-Clinical Trial Required)"

(NOT-MH-18-045)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-18-045.html

 

Notice of Extension of the Expiration Date for RFA-MH-18-705 "Development of Psychosocial

Therapeutic and Preventive Interventions for Mental Disorders (R33-Clinical Trial Required)

(NOT-MH-18-046)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-18-046.html

 

Notice of Extension of the Expiration Date for RFA-MH-18-706 "Pilot Effectiveness Trials for

Treatment, Preventive and Services Interventions (R34- Clinical Trial Required)" (NOT-MH-18-047)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-18-047.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for Promoting Research on Music

and Health: Fundamentals and Applications (R01 Clinical Trials Optional) (NOT-NS-18-090)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-18-090.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for Promoting Research on Music

and Health: Fundamentals and Applications (R21 Clinical Trials Optional) (NOT-NS-18-091)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-18-091.html

 

 

Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least one month prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.

 

NIH DEADLINES

 

Prevention of HPV-related Cancers in HIV-infected individuals: United States-Latin American-Caribbean

Clinical Trials Network: Partnership Centers (U54 Clinical Trial Required) (RFA-CA-18-018)

Deadline November 15, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-018.html

 

Limited Competition for the Continuation of Cure Glomerulonephropathy (CureGN) Participating Clinical

Centers (U01 Clinical Trial Not Allowed) (RFA-DK-18-503) – Deadline November 21, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-503.html

 

Limited Competition for the Continuation of Cure Glomerulonephropathy (CureGN) Data Coordinating

Center (U24 Clinical Trial Not Allowed) (RFA-DK-18-504) – Deadline November 21, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-504.html

 

Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER) (R01 Clinical

Trial Optional) (RFA-ES-18-007) – Deadline December 3, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-18-007.html

 

Maintain and Enrich Resource Infrastructure for Existing Environmental Epidemiology Cohorts

(R24 Clinical Trial Not Allowed) (RFA-ES-18-009) – Deadline November 6, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-18-009.html

 

Human Health Exposure Analysis Resource: Coordinating Center (U24 Clinical Trial Not Allowed)

(RFA-ES-18-010) – Deadline October 29, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-18-010.html

 

Human Health Exposure Analysis Resource: Targeted Exposure Analysis Laboratories

(U2C Clinical Trial Not Allowed) (RFA-ES-18-011) – Deadline October 29, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-18-011.html

 

Human Health Exposure Analysis Resource: UnTargeted Exposure Analysis Laboratories

(U2C Clinical Trial Not Allowed) (RFA-ES-18-012) – Deadline October 29, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-18-012.html

 

Human Health Exposure Analysis Resource: Environmental Exposure Analysis Laboratories

(U2C Clinical Trial Not Allowed) (RFA-ES-18-013) – Deadline October 29, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-18-013.html

 

Human Health Exposure Analysis Resource: Data Repository, Analysis and Science Center

(U2C Clinical Trial Not Allowed) (RFA-ES-18-014) – Deadline October 29, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-18-014.html

 

BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating

Technologies in the Human Brain (U01 Clinical Trial Required) (RFA-NS-19-001)

Deadline November 14, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-001.html

 

BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Required)

(RFA-NS-19-002) – Deadline October 30, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-002.html

 

BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Not Allowed)

(RFA-NS-19-003) – Deadline October 30, 2018
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-003.html

 

New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated

with Mental Disorders (R01 (Collab) Clinical Trial Not Allowed) (PA-18-907) – Deadline February 5, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-18-907.html

 

New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated

with Mental Disorders (R01 Clinical Trial Not Allowed) (PA-18-908) – Deadline February 5, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-18-908.html

 

Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules

(X02 Clinical Trials Not Allowed) (PAR-18-909) – Deadline October 31, 2018
https://grants.nih.gov/grants/guide/pa-files/PAR-18-909.html

 

Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules

(U01) (Clinical Trial Required) (PAR-18-910) – Deadline May 3, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-18-910.html

 

 

New Clinical Study Opportunities

***************************************************

Please note this is NOT a solicitation for study subjects

***************************************************

Several Pharmaceutical companies are looking for Principal Investigators to participate in the following clinical studies:

  • Atopic Dermatitis
  • Single Cohort Phase 4 Trial Investigating the Impact of G-CSF Primary Prophylaxis for Advanced

Stage Hodgkin’s Lymphoma Patients Treated with A+AVD

  • eSIF Study
  • Solid Tumor
  • A Multicenter, Randomized, Double Blind, Placebo-Controlled, Phase 3 Study to Determine if Oral

RTB101 (Dactolisib) Decreases the Incidence of Respiratory Tract Infections in Elderly Subjects

  • Parenteral Nutrition In Hospitalized Neonates, Preterm Infants And Pediatric Patients #118601_24

Do you need to update Parexel’s Investigator database? This is the best way to ensure you receive notice to

participate in new clinical studies based on your therapeutic area interests and experience.

Please contact Scott Davis at scott-davis@ouhsc.edu if you would like to receive more information on any of

these studies. The resulting confidentiality and/or clinical study agreement will need to be routed to the

Office of Research Administration.

Print

Name:
Email:
Subject:
Message:
x